BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 32066715)

  • 21. Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.
    Li QS; Tian C; Seabrook GR; Drevets WC; Narayan VA
    Transl Psychiatry; 2016 Sep; 6(9):e889. PubMed ID: 27622933
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of thalamic hyperactivity with treatment-resistant depression and poor response in early treatment for major depression: a resting-state fMRI study using fractional amplitude of low-frequency fluctuations.
    Yamamura T; Okamoto Y; Okada G; Takaishi Y; Takamura M; Mantani A; Kurata A; Otagaki Y; Yamashita H; Yamawaki S
    Transl Psychiatry; 2016 Mar; 6(3):e754. PubMed ID: 26954981
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacogenetics of antidepressant response: A polygenic approach.
    García-González J; Tansey KE; Hauser J; Henigsberg N; Maier W; Mors O; Placentino A; Rietschel M; Souery D; Žagar T; Czerski PM; Jerman B; Buttenschøn HN; Schulze TG; Zobel A; Farmer A; Aitchison KJ; Craig I; McGuffin P; Giupponi M; Perroud N; Bondolfi G; Evans D; O'Donovan M; Peters TJ; Wendland JR; Lewis G; Kapur S; Perlis R; Arolt V; Domschke K; ; Breen G; Curtis C; Sang-Hyuk L; Kan C; Newhouse S; Patel H; Baune BT; Uher R; Lewis CM; Fabbri C
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Apr; 75():128-134. PubMed ID: 28159590
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Humanistic outcomes in treatment resistant depression: a secondary analysis of the STAR*D study.
    DiBernardo A; Lin X; Zhang Q; Xiang J; Lu L; Jamieson C; Benson C; Lee K; Bodén R; Brandt L; Brenner P; Reutfors J; Li G
    BMC Psychiatry; 2018 Oct; 18(1):352. PubMed ID: 30373547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The burden and the challenge of treatment-resistant depression.
    Touloumis C
    Psychiatriki; 2021 Dec; 32(Supplement I):11-14. PubMed ID: 34990376
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Replication of machine learning methods to predict treatment outcome with antidepressant medications in patients with major depressive disorder from STAR*D and CAN-BIND-1.
    Nunez JJ; Nguyen TT; Zhou Y; Cao B; Ng RT; Chen J; Frey BN; Milev R; Müller DJ; Rotzinger S; Soares CN; Uher R; Kennedy SH; Lam RW
    PLoS One; 2021; 16(6):e0253023. PubMed ID: 34181661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genome-wide association studies of antidepressant class response and treatment-resistant depression.
    Li QS; Tian C; Hinds D;
    Transl Psychiatry; 2020 Oct; 10(1):360. PubMed ID: 33106475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An episode level evaluation of the treatment journey of patients with major depressive disorder and treatment-resistant depression.
    Wu B; Cai Q; Sheehan JJ; Benson C; Connolly N; Alphs L
    PLoS One; 2019; 14(8):e0220763. PubMed ID: 31393922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Understanding treatment-resistant depression using "omics" techniques: A systematic review.
    Amasi-Hartoonian N; Pariante CM; Cattaneo A; Sforzini L
    J Affect Disord; 2022 Dec; 318():423-455. PubMed ID: 36103934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment-resistant depression as risk factor for substance use disorders-a nation-wide register-based cohort study.
    Brenner P; Brandt L; Li G; DiBernardo A; Bodén R; Reutfors J
    Addiction; 2019 Jul; 114(7):1274-1282. PubMed ID: 30938020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment patterns in patients with treatment-resistant depression in Danish patients with major depressive disorder.
    Gronemann FH; Petersen J; Alulis S; Jensen KJ; Riise J; Ankarfeldt MZ; Solem EJ; Bødker N; Osler M
    J Affect Disord; 2021 May; 287():204-213. PubMed ID: 33799039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Can Machine Learning help us in dealing with treatment resistant depression? A review.
    Pigoni A; Delvecchio G; Madonna D; Bressi C; Soares J; Brambilla P
    J Affect Disord; 2019 Dec; 259():21-26. PubMed ID: 31437696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of BCL2 gene in major depression susceptibility and antidepressant treatment outcome.
    Zhang C; Wu Z; Hong W; Wang Z; Peng D; Chen J; Yuan C; Yu S; Xu L; Fang Y
    J Affect Disord; 2014 Feb; 155():288-94. PubMed ID: 24321200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidemiology of treatment resistant depression among major depressive disorder patients in Israel.
    Sharman Moser S; Chodick G; Gelerstein S; Barit Ben David N; Shalev V; Stein-Reisner O
    BMC Psychiatry; 2022 Aug; 22(1):541. PubMed ID: 35948895
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rare copy number variation in treatment-resistant major depressive disorder.
    O'Dushlaine C; Ripke S; Ruderfer DM; Hamilton SP; Fava M; Iosifescu DV; Kohane IS; Churchill SE; Castro VM; Clements CC; Blumenthal SR; Murphy SN; Smoller JW; Perlis RH
    Biol Psychiatry; 2014 Oct; 76(7):536-41. PubMed ID: 24529801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigation of early and lifetime clinical features and comorbidities for the risk of developing treatment-resistant depression in a 13-year nationwide cohort study.
    Huang SS; Chen HH; Wang J; Chen WJ; Chen HC; Kuo PH
    BMC Psychiatry; 2020 Nov; 20(1):541. PubMed ID: 33203427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A prospective study to determine the clinical utility of pharmacogenetic testing of veterans with treatment-resistant depression.
    McCarthy MJ; Chen Y; Demodena A; Leckband SG; Fischer E; Golshan S; Suppes T; Kelsoe JR
    J Psychopharmacol; 2021 Aug; 35(8):992-1002. PubMed ID: 33938307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Prevalence and National Burden of Treatment-Resistant Depression and Major Depressive Disorder in the United States.
    Zhdanava M; Pilon D; Ghelerter I; Chow W; Joshi K; Lefebvre P; Sheehan JJ
    J Clin Psychiatry; 2021 Mar; 82(2):. PubMed ID: 33989464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rare variants and biological pathways identified in treatment-refractory depression.
    McClain LL; Shaw P; Sabol R; Chedia AM; Segretti AM; Rengasamy M; Finegold DN; Pan L; Peters DG
    J Neurosci Res; 2020 Jul; 98(7):1322-1334. PubMed ID: 32128872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proteasome system dysregulation and treatment resistance mechanisms in major depressive disorder.
    Minelli A; Magri C; Barbon A; Bonvicini C; Segala M; Congiu C; Bignotti S; Milanesi E; Trabucchi L; Cattane N; Bortolomasi M; Gennarelli M
    Transl Psychiatry; 2015 Dec; 5(12):e687. PubMed ID: 26624926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.